Macropinocytosis has been implicated in cardiovascular and other disorders, yet physiological factors that initiate fluid-phase internalization and the signaling mechanisms involved remain poorly identified. The present study was designed to examine whether matrix protein thrombospondin-1 (TSP1) stimulates macrophage macropinocytosis and, if so, to investigate the potential signaling mechanism involved.
Results:
TSP1 treatment of human and murine macrophages stimulated membrane ruffle formation and pericellular solute internalization by macropinocytosis. Blockade of TSP1 cognate receptor CD47 and NADPH oxidase 1 (Nox1) signaling, inhibition of phosphoinositide 3-kinase, and transcriptional knockdown of myotubularin-related protein 6 abolished TSP1-induced macropinocytosis. Our results demonstrate that Nox1 signaling leads to dephosphorylation of actin-binding protein cofilin at Ser-3, actin remodeling, and macropinocytotic uptake of unmodified native low-density lipoprotein (nLDL), leading to foam cell formation. Finally, peritoneal chimera studies suggest the role of CD47 in macrophage lipid macropinocytosis in hypercholesterolemic ApoE−/− mice in vivo.
Innovation:
Activation of a previously unidentified TSP1-CD47 signaling pathway in macrophages stimulates direct receptor-independent internalization of nLDL, leading to significant lipid accumulation and foam cell formation. These findings reveal a new paradigm in which delimited Nox1-mediated redox signaling, independent of classical lipid oxidation, contributes to early propagation of vascular inflammatory disease.
Conclusions:
The findings of the present study demonstrate a new mechanism of solute uptake with implications for a wide array of cell types, including macrophages, dendritic cells, and cancer cells, and multiple pathological conditions in which matrix proteins are upregulated. Antioxid. Redox Signal. 26, 886–901.
Get full access to this article
View all access options for this article.
References
1.
Al GhoulehI, FrazzianoG, RodriguezAI, CsányiG, ManiarS, St CroixCM, KelleyEE, EganaLA, SongGJ, BiselloA, LeeYJ, and PaganoPJ. Aquaporin 1, Nox1, and Ask1 mediate oxidant-induced smooth muscle cell hypertrophy. Cardiovasc Res, 97: 134–142, 2013.
2.
AleksandrowiczP, MarziA, BiedenkopfN, BeimfordeN, BeckerS, HoenenT, FeldmannH, and SchnittlerHJ. Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. J Infect Dis, 204Suppl 3: S957–S967, 2011.
3.
ArakiN, HataeT, FurukawaA, and SwansonJA. Phosphoinositide-3-kinase-independent contractile activities associated with Fcgamma-receptor-mediated phagocytosis and macropinocytosis in macrophages. J Cell Sci, 116: 247–257, 2003.
4.
ArakiN, JohnsonMT, and SwansonJA. A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J Cell Biol, 135: 1249–1260, 1996.
5.
AzimifarSB, BottcherRT, ZanivanS, GrashoffC, KrugerM, LegateKR, MannM, and FasslerR. Induction of membrane circular dorsal ruffles requires co-signalling of integrin-ILK-complex and EGF receptor. J Cell Sci, 125: 435–448, 2012.
6.
BabaevVR, GleavesLA, CarterKJ, SuzukiH, KodamaT, FazioS, and LintonMF. Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A. Arterioscler Thromb Vasc Biol, 20: 2593–2599, 2000.
7.
BauerEM, QinY, MillerTW, BandleRW, CsányiG, PaganoPJ, BauerPM, SchnermannJ, RobertsDD, and IsenbergJS. Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation. Cardiovasc Res, 88: 471–481, 2010.
8.
BedardK and KrauseKH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev, 87: 245–313, 2007.
9.
BohdanowiczM and GrinsteinS. Role of phospholipids in endocytosis, phagocytosis, and macropinocytosis. Physiol Rev, 93: 69–106, 2013.
10.
BornsteinP and SageEH. Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol, 14: 608–616, 2002.
11.
BrownDI and GriendlingKK. Nox proteins in signal transduction. Free Radic Biol Med, 47: 1239–1253, 2009.
12.
CommissoC, DavidsonSM, Soydaner-AzelogluRG, ParkerSJ, KamphorstJJ, HackettS, GrabockaE, NofalM, DrebinJA, ThompsonCB, RabinowitzJD, MetalloCM, Vander HeidenMG, and Bar-SagiD. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature, 497: 633–637, 2013.
13.
CsányiG and PaganoPJ. Strategies aimed at Nox4 oxidase inhibition employing peptides from Nox4 B-Loop and C-Terminus and p22 (phox) N-Terminus: an elusive target. Int J Hypertens, 2013: 842827, 2013.
14.
CsányiG, TaylorWR, and PaganoPJ. NOX and inflammation in the vascular adventitia. Free Radic Biol Med, 47: 1254–1266, 2009.
15.
CsányiG, YaoM, RodriguezAI, Al GhoulehI, Sharifi-SanjaniM, FrazzianoG, HuangX, KelleyEE, IsenbergJS, and PaganoPJ. Thrombospondin-1 regulates blood flow via CD47 receptor-mediated activation of NADPH oxidase 1. Arterioscler Thromb Vasc Biol, 32: 2966–2973, 2012.
16.
DavtyanTK, AvetisyanSA, and HakobyanGS. Neutrophil F-actin dynamics in familial mediterranean fever: the unequal effect of colchicine on activated neutrophils. Antiinflamm Antiallergy Agents Med Chem, 12: 165–172, 2013.
17.
DesMaraisV, GhoshM, EddyR, and CondeelisJ. Cofilin takes the lead. J Cell Sci, 118: 19–26, 2005.
18.
EsterbauerH, GebickiJ, PuhlH, and JurgensG. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med, 13: 341–390, 1992.
19.
FebbraioM, PodrezEA, SmithJD, HajjarDP, HazenSL, HoffHF, SharmaK, and SilversteinRL. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest, 105: 1049–1056, 2000.
GhoshalP, SinglaB, LinH, FeckDM, Cantu-MedellinN, KelleyEE, HaighS, FultonD, and CsányiG. Nox2-mediated PI3K and cofilin activation confers alternate redox control of macrophage pinocytosis. Antioxid Redox Signal, 26: 902–916, 2016.
22.
HeineckeJW, BakerL, RosenH, and ChaitA. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J Clin Invest, 77: 757–761, 1986.
23.
HeyworthPG, KnausUG, SettlemanJ, CurnutteJT, and BokochGM. Regulation of NADPH oxidase activity by Rac GTPase activating protein(s). Mol Biol Cell, 4: 1217–1223, 1993.
24.
IsenbergJS, AnnisDS, PendrakML, PtaszynskaM, FrazierWA, MosherDF, and RobertsDD. Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses. J Biol Chem, 284: 1116–1125, 2009.
25.
Jandeleit-DahmK, RumbleJ, CoxAJ, KellyDJ, DziadekM, CooperME, and GilbertRE. SPARC gene expression is increased in diabetes-related mesenteric vascular hypertrophy. Microvasc Res, 59: 61–71, 2000.
26.
KoivusaloM, WelchC, HayashiH, ScottCC, KimM, AlexanderT, TouretN, HahnKM, and GrinsteinS. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J Cell Biol, 188: 547–563, 2010.
27.
KruthHS, HuangW, IshiiI, and ZhangWY. Macrophage foam cell formation with native low density lipoprotein. J Biol Chem, 277: 34573–34580, 2002.
28.
KruthHS, JonesNL, HuangW, ZhaoB, IshiiI, ChangJ, CombsCA, MalideD, and ZhangWY. Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low density lipoprotein. J Biol Chem, 280: 2352–2360, 2005.
29.
LiJM, MullenAM, YunS, WientjesF, BrounsGY, ThrasherAJ, and ShahAM. Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha. Circ Res, 90: 143–150, 2002.
30.
LiuZ and RochePA. Macropinocytosis in phagocytes: regulation of MHC class-II-restricted antigen presentation in dendritic cells. Front Physiol, 6: 1, 2015.
MaekawaM, TerasakaS, MochizukiY, KawaiK, IkedaY, ArakiN, SkolnikEY, TaguchiT, and AraiH. Sequential breakdown of 3-phosphorylated phosphoinositides is essential for the completion of macropinocytosis. Proc Natl Acad Sci U S A, 111: E978–E987, 2014.
33.
ManeaA, TanaseLI, RaicuM, and SimionescuM. Jak/STAT signaling pathway regulates nox1 and nox4-based NADPH oxidase in human aortic smooth muscle cells. Arterioscler Thromb Vasc Biol, 30: 105–112, 2010.
34.
McCrohanMB, HuangSW, SleasmanJW, KleinPA, and KaoKJ. Plasma thrombospondin as an indicator of intravascular platelet activation in patients with vasculitis. Thromb Haemost, 58: 850–852, 1987.
35.
MooreKJ, KunjathoorVV, KoehnSL, ManningJJ, TsengAA, SilverJM, McKeeM, and FreemanMW. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J Clin Invest, 115: 2192–2201, 2005.
36.
MouraR, TjwaM, VandervoortP, Van KerckhovenS, HolvoetP, and HoylaertsMF. Thrombospondin-1 deficiency accelerates atherosclerotic plaque maturation in ApoE−/− mice. Circ Res, 103: 1181–1189, 2008.
37.
NishitaM, WangY, TomizawaC, SuzukiA, NiwaR, UemuraT, and MizunoK. Phosphoinositide 3-kinase-mediated activation of cofilin phosphatase Slingshot and its role for insulin-induced membrane protrusion. J Biol Chem, 279: 7193–7198, 2004.
38.
NyatiMK, MorganMA, FengFY, and LawrenceTS. Integration of EGFR inhibitors with radiochemotherapy. Nat Rev Cancer, 6: 876–885, 2006.
39.
OrthJD, KruegerEW, WellerSG, and McNivenMA. A novel endocytic mechanism of epidermal growth factor receptor sequestration and internalization. Cancer Res, 66: 3603–3610, 2006.
40.
RanayhossainiDJ, RodriguezAI, SahooS, ChenBB, MallampalliRK, KelleyEE, CsányiG, GladwinMT, RomeroG, and PaganoPJ. Selective recapitulation of conserved and nonconserved regions of putative NOXA1 protein activation domain confers isoform-specific inhibition of Nox1 oxidase and attenuation of endothelial cell migration. J Biol Chem, 288: 36437–36450, 2013.
41.
RejmanJ, OberleV, ZuhornIS, and HoekstraD. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J, 377: 159–169, 2004.
42.
RidleyAJ, PatersonHF, JohnstonCL, DiekmannD, and HallA. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell, 70: 401–410, 1992.
43.
SarkarK, KruhlakMJ, ErlandsenSL, and ShawS. Selective inhibition by rottlerin of macropinocytosis in monocyte-derived dendritic cells. Immunology, 116: 513–524, 2005.
44.
SheehanAL, CarrellS, JohnsonB, StanicB, BanfiB, and MillerFJJr. Role for Nox1 NADPH oxidase in atherosclerosis. Atherosclerosis, 216: 321–326, 2011.
45.
SteninaOI, KrukovetsI, WangK, ZhouZ, ForudiF, PennMS, TopolEJ, and PlowEF. Increased expression of thrombospondin-1 in vessel wall of diabetic Zucker rat. Circulation, 107: 3209–3215, 2003.
46.
StockerR and KeaneyJFJr. Role of oxidative modifications in atherosclerosis. Physiol Rev, 84: 1381–1478, 2004.
47.
SubtilA, HemarA, and Dautry-VarsatA. Rapid endocytosis of interleukin 2 receptors when clathrin-coated pit endocytosis is inhibited. J Cell Sci, 107 (Pt 12): 3461–3468, 1994.
48.
SuzukiH, KuriharaY, TakeyaM, KamadaN, KataokaM, JishageK, UedaO, SakaguchiH, HigashiT, SuzukiT, TakashimaY, KawabeY, CynshiO, WadaY, HondaM, KuriharaH, AburataniH, DoiT, MatsumotoA, AzumaS, NodaT, ToyodaY, ItakuraH, YazakiY, KodamaT, et al.A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature, 386: 292–296, 1997.
49.
SwansonJA. Phorbol esters stimulate macropinocytosis and solute flow through macrophages. J Cell Sci, 94 (Pt 1): 135–142, 1989.
50.
TkachenkoE, LutgensE, StanRV, and SimonsM. Fibroblast growth factor 2 endocytosis in endothelial cells proceed via syndecan-4-dependent activation of Rac1 and a Cdc42-dependent macropinocytic pathway. J Cell Sci, 117: 3189–3199, 2004.
51.
TsengHY, LiuZM, and HuangHS. NADPH oxidase-produced superoxide mediates EGFR transactivation by c-Src in arsenic trioxide-stimulated human keratinocytes. Arch Toxicol, 86: 935–945, 2012.
52.
UpstonJM, NiuX, BrownAJ, MashimaR, WangH, SenthilmohanR, KettleAJ, DeanRT, and StockerR. Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis. Am J Pathol, 160: 701–710, 2002.
53.
YoshidaS, HoppeAD, ArakiN, and SwansonJA. Sequential signaling in plasma-membrane domains during macropinosome formation in macrophages. J Cell Sci, 122: 3250–3261, 2009.
54.
ZhuXD, ZhuangY, BenJJ, QianLL, HuangHP, BaiH, ShaJH, HeZG, and ChenQ. Caveolae-dependent endocytosis is required for class A macrophage scavenger receptor-mediated apoptosis in macrophages. J Biol Chem, 286: 8231–8239, 2011.
55.
ZielonkaJ, Vasquez-VivarJ, and KalyanaramanB. Detection of 2-hydroxyethidium in cellular systems: a unique marker product of superoxide and hydroethidine. Nat Protoc, 3: 8–21, 2008.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
